The Company recorded $1.0 million and $9.2 million of restructuring and related charges during the three months ended December 31, 2024 and 2023, respectively. The Company recorded $2.3 million and $11.9 million of restructuring and related charges during the six months ended December 31, 2024 and 2023, respectively. These charges primarily included severance and benefits costs and professional fees related to the restructuring plans executed in prior years.

During the third quarter of fiscal 2024, the Company executed a global reduction-in-force plan targeted towards the reorganization of the Company's research and development and sales and marketing functions to align the Company's workforce with its strategic priorities and to focus on specific geographies and industry segments with higher growth opportunities (the “Q3 2024 Plan”). During the three and six months ended December 31, 2024, the Company recorded restructuring charges of $0.9 million and $1.5 million, respectively, related to the Q3 2024 Plan, which primarily consisted of additional severance and benefits expenses, legal and consulting fees.

During the second quarter of fiscal 2024, the Company executed a global reduction-in-force plan to rebalance its workforce to create greater efficiency and improve execution, in alignment with the Company's business and strategic priorities, while reducing its ongoing operating expenses to address reduced revenue and macro-economic conditions (the “Q2 2024 Plan”). During the three and six months ended December 31, 2024, the Company recorded restructuring charges of less than $0.1 million and $0.6 million related to the Q2 2024 Plan, which primarily consisted of additional severance and benefits expenses, legal fees and consulting fees. During the three months ended December 31, 2023, the Company recorded restructuring charges of $8.8 million related to the Q2 2024 Plan, which primarily consisted of severance and benefits expenses, legal and consulting fees.

Through December 31, 2024, the Company has incurred $29.1 million in restructuring charges under the Q2 2024 Plan and Q3 2024 Plan which primarily related to severance and benefits costs. The Company expects to complete these ongoing restructuring plans by the end of fiscal year 2025 and expects to incur approximately $1.3 million in additional charges for the Q2 2024 Plan and the Q3 2024 Plan.

During the third quarter of fiscal 2023, the Company initiated a restructuring plan to transform its business infrastructure and reduce its facilities footprint and the facilities related charges (the “2023 Plan”). As part of this project, the Company is moved engineering labs from its San Jose, California location to its Salem, New Hampshire location. This move is expected to help reduce the cost of operating the Company's labs. During the six months ended December 31, 2024, the Company recorded restructuring charges of $0.1 million related to the 2023 Plan. The Company expects to complete the 2023 Plan by the end of fiscal year 2025 and expects to incur charges of $1.6 million throughout this period, primarily for asset disposals and other fees. Through December 31, 2024, the

Company has incurred $6.6 million of restructuring charges under the 2023 Plan, which primarily consisted of $5.9 million in accelerated depreciation on lab leasehold improvements and $0.7 million in other charges related to moving expenses and asset disposal costs.

During the first quarter of fiscal 2024, the Company initiated a reduction-in-force plan to rebalance the workforce to create greater efficiency and improve execution in alignment with the Company's business and strategic priorities (the “Q1 2024 Plan”). It consisted primarily of workforce reduction to drive productivity in research and development, sales and marketing and provide efficiency across operations and general and administrative functions. During the three and six months ended December 31, 2023, the Company incurred charges of $0.2 million and $2.9 million, respectively related to the Q1 2024 Plan. As of June 30, 2024, the plan was completed.

Restructuring liabilities are recorded in “Other accrued liabilities” in the accompanying condensed consolidated balance sheets. As of December 31, 2024 and 2023, the restructuring liability was $3.4 million and $6.2 million, respectively related to these restructuring plans.

The following table summarizes the activity related to the Company’s restructuring and related liabilities during the following periods (in thousands):


	Three Months Ended						Six Months Ended
	December 31, 2024			December 31, 2023			December 31, 2024			December 31, 2023
Balance at beginning of period	$	4,393		$	925		$	11,469		$	—
Period charges		1,134			9,412			2,707			12,188
Period reversals		(97	)		(173	)		(393	)		(258	)
Period payments		(2,032	)		(3,972	)		(10,385	)		(5,738	)
Balance at end of period	$	3,398		$	6,192		$	3,398		$	6,192